Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

12.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.2K
Introduction to Hemostasis01:05

Introduction to Hemostasis

13.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.4K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in the regulation and function of cellular immunity in Drosophila.

PLoS genetics·2026
Same author

PROOF OF CONCEPT FOR A DEVICE TO STANDARDIZE CELLULAR MIGRATION ASSAY EXPERIMENTS.

Proceedings of the ... Design of Medical Devices Conference. Design of Medical Devices Conference·2026
Same author

Impacts of Morphology and Elasticity on Cancer Cell Deformation in Shear-flows.

bioRxiv : the preprint server for biology·2026
Same author

A TRPV4-dependent calcium signaling axis regulates lamellipodial actin architecture to promote cell migration.

Current biology : CB·2026
Same author

Management of Otomycosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025
Same author

The impacts of shape in lateral migration of cancer cells in a microchannel.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jan 18, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

Talin autoinhibition is required for normal hemostasis.

Bhavya Venkatesh1, Kalyan Golla2, Felix Hong2,3

  • 1Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.

Platelets
|September 8, 2025
PubMed
Summary

Talin autoinhibition is crucial for hemostasis. Blocking this autoinhibition in mice led to defective hemostasis and impaired platelet aggregation, revealing a distinct role for talin in platelet function.

Keywords:
Blood plateletsintegrin activationintegrin outside-in signalingtalin autoinhibition

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.4K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.7K

Related Experiment Videos

Last Updated: Jan 18, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.4K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.7K

Area of Science:

  • Cell biology
  • Hematology
  • Biochemistry

Background:

  • Integrins are key adhesion receptors in platelets, mediating adhesion and aggregation.
  • Talin regulates integrin activity through its intracellular binding to the β-tail, but its function is controlled by autoinhibition.

Purpose of the Study:

  • To investigate the role of talin autoinhibition in platelet function and hemostasis.
  • To determine if blocking talin autoinhibition affects platelet integrin signaling and hemostatic processes.

Main Methods:

  • Utilized a Tln1E1770A mutant mouse model with a point mutation blocking talin autoinhibition.
  • Assessed hemostasis using a tail bleeding assay.
  • Analyzed platelet aggregation and clot retraction in isolated platelets from mutant mice.

Main Results:

  • Tln1E1770A mutant mice exhibited defective hemostasis and impaired tail bleeding.
  • Platelets from Tln1E1770A mice showed disrupted aggregation and delayed clot retraction.
  • Contrary to expectations, integrin activation was not increased in platelets with defective talin autoinhibition, suggesting a novel role.

Conclusions:

  • Talin autoinhibition is a critical regulatory mechanism in platelets during hemostasis.
  • The function of talin in platelets during hemostasis is distinct from its role in inside-out integrin signaling.
  • This study highlights a previously unrecognized regulatory role of talin autoinhibition in platelet biology.